Coronary Artery Disease - Reporting and Data System
Updates to Article Attributes
The Coronary Artery Disease - Reporting and Data System (CAD-RADS) TMclassification is proposeda standardized findings communication method and clinical decision aid relevant to coronary CT angiography. The system was created by a collaboration of the Society for Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR), and the and North American Society for Cardiovascular Imaging (NASCI), last updated and was also endorsed by the American College of Cardiology (ACC). The system was published in 20161.
This recommendationA CAD-RADS classification is applied per patient, representing the most severely obstructive coronary artery lesion identified. Each category describes an imaging interpretation as well as further management recommendations. This system is intended for patients with two groups of patientsdifferent clinical presentations:
- patients presenting with stable chest pain
- patients presenting with acute chest pain, negative first troponin, negative or
non-diagnosticnondiagnostic electrocardiogram, and low to intermediate risk
CAD-RADS for patients presenting with stable chest pain.
-
CAD-RADS 0degree of coronary stenosis is 0%documented absence of CADfurther cardiac investigation - none
-
CAD-RADS 1degree of coronary stenosis is 1%-24% (minimal)minimal non-obstructive CADfurther cardiac investigation - none
-
CAD-RADS 2degree of coronary stenosis is 25%-49% (mild)mild non-obstructive CADfurther cardiac investigation - none
-
CAD-RADS 3degree of coronary stenosis is 50%-69% (moderate).moderate stenosisconsider functional assessment.
-
CAD-RADS 4A-
degree of coronary stenosis is70%-99% (severe) severe stenosisconsider angiography or functional assessment
-
-
CAD-RADS 4Bleft main >50% or three-vessel disease (>70%)severe stenosisangiography recommended
-
CAD-RADS 5-
coronary stenosis is100% (total occlusion) total coronary occlusionangiography recommended
-
-
CAD-RADS Nnon-diagnostic studyobstructive CAD cannot be excludedadditional or alternative evaluation may be needed
*CAD - coronary artery disease
CAD-RADS for patients presenting with acute chest pain, negative first troponin, negative or non-diagnostic electrocardiogram and low to intermediate risk (Thrombolysis In Myocardial Infarction (TIMI) risk score <4) (emergency department or hospital setting).
Interpretation categories
Stable chest pain
-
CAD-RADS 0
-
degree: documented absence of coronarystenosis isartery disease- 0%
-
acutemaximal coronarysyndrome is highly unlikelystenosis and no plaque
-
CAD-RADS 1: minimal nonobstructive coronary artery disease
-
degree of1-24% maximal coronary stenosisis 1%-24% (minimal)= minimal stenosis, or -
acute coronary syndrome is highly unlikelyplaque with no stenosis (positive remodeling)
-
-
CAD-RADS 2: mild nonobstructive coronary artery disease
-
degree of25-49% maximal coronary stenosisis 25%-49% (mild)= mild stenosis
-
-
CAD-RADS 3: moderate stenosis
- 50-69% maximal coronary stenosis
-
CAD-RADS 4: severe stenosis
- CAD-RADS 4A: 70-99% maximal coronary stenosis
- CAD-RADS 4B: left main >50% stenosis or three-vessel obstructive (≥70% stenosis) disease
-
CAD-RADS 5: total coronary occlusion
- 100% maximal coronary stenosis = total occlusion
-
CAD-RADS N: obstructive coronary artery disease cannot be excluded
- nondiagnostic study
Acute chest pain, negative first troponin, negative or non-diagnostic electrocardiogram, and low to intermediate risk
-
CAD-RADS 0: acute coronary syndrome
ishighly unlikely- 0% maximal coronary stenosis
-
CAD-RADS 1: acute coronary syndrome highly unlikely
- 1-24% maximal coronary stenosis, or
- plaque with no stenosis (positive remodeling)
-
CAD-RADS 2: acute coronary syndrome unlikely
- 25-49% maximal coronary stenosis
- modifier 2/V: vulnerable/high risk plaque
-
CAD-RADS 3
degree of coronary stenosis is 50%-69% (moderate)-
: acute coronary syndrome
is possiblepossible- 50-69% maximal coronary stenosis
-
CAD-RADS
4A4degree of coronary stenosis is 70%-99% (severe)- : acute coronary syndrome
is likely
- CAD-RADS 4A: 70-99% maximal coronary stenosis
-
CAD-RADS 4B
-
left: left main >50% stenosis or three-vesseldiseaseobstructive (>70≥70% stenosis) -
acute coronary syndrome is likelydisease
-
-
CAD-RADS 5
coronary stenosis is 100% (total occlusion)-
: acute coronary syndrome
isvery likely- 100% maximal coronary stenosis = total occlusion
-
CAD-RADS N
non-diagnostic study-
: acute coronary syndrome cannot be excluded
- nondiagnostic study
Management recommendations
TherapeuticRecommendations for further cardiac investigation and therapeutic approach accompanies each CAD-RADS category and is different for these two groups of patients.Management of patients presenting with stableStable chest pain
.-
CAD-RADS 0
-
reassuranceno further cardiac investigation -
reassurance; consider
non-atheroscleroticnonatherosclerotic causes of chest pain
-
-
CAD-RADS 1
- no further cardiac investigation
- consider
non-atheroscleroticnonatherosclerotic causes of chest pain -
consider; consider preventive therapy and risk factor modification
-
CAD-RADS 2
- no further cardiac investigation
- consider non-atherosclerotic causes of chest pain
-
; consider preventive therapy and risk factor modification, particularly for patients with
non-obstructivenonobstructive plaque in multiple segments
-
CAD-RADS 3
- consider functional assessment
- consider symptom-guided anti-ischaemic and preventive pharmacotherapy as well as risk factor modification per guideline-directed care
- ; other treatments should be considered per guideline-directed care
-
CAD-RADS 4
- CAD-RADS 4A: consider invasive coronary angiography or functional assessment
- CAD-RADS 4B: invasive coronary angiography is recommended
- consider symptom-guided anti-ischaemic and preventive pharmacotherapy as well as risk factor modification per guideline-directed care
- ; other treatments (including options of revascularization) should be considered per guideline-directed care
-
CAD-RADS 5
- consider invasive coronary angiography and/or viability assessment
- consider symptom-guided anti-ischaemic and preventive pharmacotherapy as well as risk factors modification per guideline-directed care
-
other; other treatments (including options of revascularization) should be considered per guideline-directed care.
-
CAD-RADS N
- additional or alternative evaluation may be needed
Management of patients presenting with acute
Acute chest pain, negative first troponin, negative or non-diagnostic electrocardiogram, and low to intermediate risk
(Thrombolysis In Myocardial Infarction (TIMI) risk score <4) (emergency department or hospital setting).-
CAD-RADS 0
- no further evaluation of
ACSacute coronary syndrome is required -
consider; consider otheraetiologiesetiologies
- no further evaluation of
-
CAD-RADS 1
- consider evaluation of non
-ACS aetiology-acute coronary syndrome etiology, if normal troponin and no ECG changes - consider referral for outpatient follow-up for preventive therapy and risk factor modification
- consider evaluation of non
-
CAD-RADS 2
- consider evaluation of non
-ACS aetiology-acute coronary syndrome etiology, if normal troponin and no ECG changes - consider referral for outpatient follow-up for preventive therapy and risk factor modification
- if clinical suspicion of
ACSacute coronary syndrome is high or if high-risk plaque features are noted, consider hospital admission with cardiology consultation
- consider evaluation of non
-
CAD-RADS 3
- consider hospital admission with cardiology consultation, functional testing, and/or
ICAinvasive coronary angiography for evaluation and management. - recommendation for anti
-ischaemic-ischemic and preventive management should be considered as well as risk factor modification -
other; other treatments should be considered if presence ofhaemodynamically-significanthemodynamically significant lesion.
- consider hospital admission with cardiology consultation, functional testing, and/or
-
CAD-RADS 4
- consider hospital admission with cardiology consultation
. Further; further evaluation withICAinvasive coronary angiography and revascularization as appropriate. - recommendation for anti-ischaemic and preventive management should be considered as well as risk factor modification
- consider hospital admission with cardiology consultation
-
CAD-RADS 5
- consider expedited
ICAinvasive coronary angiography on a timely basis and revascularization if appropriate if acute occlusion - recommendation for anti-ischaemic and preventive management should be considered as well as risk factor modifications.
- consider expedited
-
CAD-RADS N
- additional or alternative evaluation for
ACSacute coronary syndrome is needed
- additional or alternative evaluation for
* ACS - acute coronary syndromeModifiers
If more than one modifier is present, the symbol “/” (slash) should follow each modifier in the following order:
- modifier N
(non-diagnostic): nondiagnostic - modifier S
(stent): stent - modifier G
(graft): graft - modifier V
(vulnerability): vulnerability
For example:
- non-interpretable coronary stent without evidence of other obstructive coronary disease: modifier S = CAD-RADS N/S
- presence of stent and a new moderate stenosis showing a plaque with high-risk features: modifiers S and V=CAD-RADS 3/S/V
- presence of stent, grafts and non-evaluable segments due to metal artifacts: modifiers S and G=CAD-RADS N/S/G
- presence of patent left internal mammary artery (LIMA) to the left anterior descending artery(LAD) and expected occluded proximal LAD. Mild non-obstructive stenosis in the right coronary artery (RCA) and left circumflex artery (LCx. modifier G = CAD-RADS 2/G
- for a patient with severe stenosis (70-99%) in one segment and a non-diagnostic area in another segment, the study should be graded as CAD-RADS 4/N
See also
-
-<p><strong>Coronary Artery Disease - Reporting and Data System (CAD-RADS</strong><sup>TM</sup><strong>) </strong>classification is proposed by the Society for Cardiovascular Computed Tomography (SCCT), the <a href="/articles/american-college-of-radiology">American College of Radiology (ACR)</a>, and the North American Society for Cardiovascular Imaging (NASCI), last updated in 2016.</p><p>This recommendation is intended for two groups of patients:</p><ul>- +<p>The <strong>Coronary Artery Disease - Reporting and Data System (CAD-RADS</strong><strong>) </strong>is a standardized findings communication method and clinical decision aid relevant to <a href="/articles/cardiac-ct-1">coronary CT angiography</a>. The system was created by a collaboration of the Society for Cardiovascular Computed Tomography (SCCT), <a href="/articles/american-college-of-radiology">American College of Radiology (ACR)</a>, and North American Society for Cardiovascular Imaging (NASCI) and was also endorsed by the American College of Cardiology (ACC). The system was published in 2016 <sup>1</sup>.</p><p>A CAD-RADS classification is applied per patient, representing the most severely obstructive coronary artery lesion identified. Each category describes an imaging interpretation as well as further management recommendations. This system is intended for patients with two different clinical presentations:</p><ul>
-<li>patients presenting with acute chest pain, negative first troponin, negative or non-diagnostic electrocardiogram, and low to intermediate risk</li>-</ul><p>CAD-RADS for patients presenting with stable chest pain.</p><ul>- +<li>patients presenting with acute chest pain, negative first troponin, negative or nondiagnostic electrocardiogram, and low to intermediate risk (Thrombolysis In Myocardial Infarction (TIMI) risk score <4) (emergency department or hospital setting)</li>
- +</ul><h4>Interpretation categories</h4><h5>Stable chest pain</h5><ul>
-<strong>CAD-RADS 0</strong><ul>-<li>degree of coronary stenosis is 0%</li>-<li>documented absence of CAD</li>-<li>further cardiac investigation - none</li>-</ul>- +<strong>CAD-RADS 0: documented absence of coronary artery disease</strong><ul><li>0% maximal coronary stenosis and no plaque</li></ul>
-<strong>CAD-RADS 1</strong><ul>-<li>degree of coronary stenosis is 1%-24% (minimal)</li>-<li>minimal non-obstructive CAD </li>-<li>further cardiac investigation - none</li>- +<strong>CAD-RADS 1: minimal nonobstructive coronary artery disease</strong><ul>
- +<li>1-24% maximal coronary stenosis = minimal stenosis, or</li>
- +<li>plaque with no stenosis (positive remodeling)</li>
-<strong>CAD-RADS 2</strong><ul>-<li>degree of coronary stenosis is 25%-49% (mild)</li>-<li>mild non-obstructive CAD </li>-<li>further cardiac investigation - none</li>-</ul>- +<strong>CAD-RADS 2: mild nonobstructive coronary artery disease</strong><ul><li>25-49% maximal coronary stenosis = mild stenosis</li></ul>
-<strong>CAD-RADS 3 </strong><ul>-<li>degree of coronary stenosis is 50%-69% (moderate).</li>-<li>moderate stenosis </li>-<li>consider functional assessment.</li>-</ul>- +<strong>CAD-RADS 3: moderate stenosis</strong><ul><li>50-69% maximal coronary stenosis</li></ul>
-<strong>CAD-RADS 4A</strong><ul>-<li>degree of coronary stenosis is <strong> </strong>70%-99% (severe)</li>-<li>severe stenosis </li>-<li>consider angiography or functional assessment</li>-</ul>-</li>- +<strong>CAD-RADS 4</strong><strong>: severe stenosis</strong><ul>
-<strong>CAD-RADS 4B</strong><ul>-<li>left main >50% or three-vessel disease (>70%)</li>-<li>severe stenosis </li>-<li>angiography recommended</li>-</ul>-</li>- +<strong>CAD-RADS 4A</strong>: 70-99% maximal coronary stenosis</li>
-<strong>CAD-RADS 5</strong><ul>-<li>coronary stenosis is <strong> </strong>100% (total occlusion)</li>-<li>total coronary occlusion </li>-<li>angiography recommended</li>- +<strong>CAD-RADS 4B</strong>: left main >50% stenosis or three-vessel obstructive (≥70% stenosis) disease</li>
-<strong>CAD-RADS N</strong><ul>-<li>non-diagnostic study</li>-<li>obstructive CAD cannot be excluded</li>-<li>additional or alternative evaluation may be needed</li>-</ul>- +<strong>CAD-RADS 5: total coronary occlusion</strong><ul><li>100% maximal coronary stenosis = total occlusion</li></ul>
-</ul><p>*CAD - coronary artery disease </p><p><strong>CAD-RADS for patients presenting with acute chest pain, negative first troponin, negative or non-diagnostic electrocardiogram and low to intermediate risk</strong> (Thrombolysis In Myocardial Infarction (TIMI) risk score <4) (emergency department or hospital setting)<strong>. </strong></p><ul>-<strong>CAD-RADS 0</strong><ul>-<li>degree of coronary stenosis is 0%</li>-<li>acute coronary syndrome is highly unlikely </li>-</ul>- +<strong>CAD-RADS N: obstructive coronary artery disease cannot be excluded</strong><ul><li>nondiagnostic study</li></ul>
- +</ul><h5>Acute chest pain, negative first troponin, negative or non-diagnostic electrocardiogram, and low to intermediate risk</h5><ul>
-<strong>CAD-RADS 1</strong><ul>-<li>degree of coronary stenosis is 1%-24% (minimal)</li>-<li>acute coronary syndrome is highly unlikely </li>-</ul>- +<strong>CAD-RADS 0: acute coronary syndrome highly unlikely</strong><ul><li>0% maximal coronary stenosis</li></ul>
-<strong>CAD-RADS 2</strong><ul>-<li>degree of coronary stenosis is 25%-49% (mild)</li>-<li>acute coronary syndrome is unlikely</li>- +<strong>CAD-RADS 1: acute coronary syndrome highly unlikely</strong><ul>
- +<li>1-24% maximal coronary stenosis, or</li>
- +<li>plaque with no stenosis (positive remodeling)</li>
-<strong>CAD-RADS 3 </strong><ul>-<li>degree of coronary stenosis is 50%-69% (moderate)</li>-<li>acute coronary syndrome is possible</li>- +<strong>CAD-RADS 2: acute coronary syndrome unlikely</strong><ul>
- +<li>25-49% maximal coronary stenosis</li>
- +<li>modifier 2/V: vulnerable/high risk plaque</li>
-<strong>CAD-RADS 4A</strong><ul>-<li>degree of coronary stenosis is 70%-99% (severe)</li>-<li>acute coronary syndrome is likely</li>-</ul>- +<strong>CAD-RADS 3: acute coronary syndrome possible</strong><ul><li>50-69% maximal coronary stenosis</li></ul>
-<strong>CAD-RADS 4B</strong><ul>-<li>left main >50% or three-vessel disease (>70%)</li>-<li>acute coronary syndrome is likely</li>- +<strong>CAD-RADS 4</strong><strong>: acute coronary syndrome likely</strong><ul>
- +<li>
- +<strong>CAD-RADS 4A</strong>: 70-99% maximal coronary stenosis</li>
- +<li>
- +<strong>CAD-RADS 4B</strong>: left main >50% stenosis or three-vessel obstructive (≥70% stenosis) disease</li>
-<strong>CAD-RADS 5</strong><ul>-<li>coronary stenosis is 100% (total occlusion)</li>-<li>acute coronary syndrome is very likely</li>-</ul>- +<strong>CAD-RADS 5: acute coronary syndrome very likely</strong><ul><li>100% maximal coronary stenosis = total occlusion</li></ul>
-<strong>CAD-RADS N</strong><ul>-<li>non-diagnostic study</li>-<li>acute coronary syndrome cannot be excluded</li>-</ul>- +<strong>CAD-RADS N: acute coronary syndrome cannot be excluded</strong><ul><li>nondiagnostic study</li></ul>
-</ul><h4>Management</h4><p>Therapeutic approach is different for these two groups of patients. <strong> </strong></p><p><strong>Management of patients presenting with stable chest pain. </strong></p><ul>- +</ul><h4>Management recommendations</h4><p>Recommendations for further cardiac investigation and therapeutic approach accompanies each CAD-RADS category and is different for these two groups of patients.</p><h5>Stable chest pain</h5><ul>
-<li>reassurance</li>-<li>consider non-atherosclerotic causes of chest pain </li>- +<li>no further cardiac investigation</li>
- +<li>reassurance; consider nonatherosclerotic causes of chest pain </li>
-<li>consider non-atherosclerotic causes of chest pain</li>-<li>consider preventive therapy and risk factor modification </li>- +<li>no further cardiac investigation</li>
- +<li>consider nonatherosclerotic causes of chest pain; consider preventive therapy and risk factor modification </li>
-<li>consider non-atherosclerotic causes of chest pain</li>-<li>consider preventive therapy and risk factor modification, particularly for patients with non-obstructive plaque in multiple segments</li>- +<li>no further cardiac investigation</li>
- +<li>consider non-atherosclerotic causes of chest pain; consider preventive therapy and risk factor modification, particularly for patients with nonobstructive plaque in multiple segments</li>
-<li>consider symptom-guided anti-ischaemic and preventive pharmacotherapy as well as risk factor modification per guideline-directed care</li>-<li>other treatments should be considered per guideline-directed care </li>- +<li>consider functional assessment</li>
- +<li>consider symptom-guided anti-ischaemic and preventive pharmacotherapy as well as risk factor modification per guideline-directed care; other treatments should be considered per guideline-directed care </li>
-<li>consider symptom-guided anti-ischaemic and preventive pharmacotherapy as well as risk factor modification per guideline-directed care</li>-<li>other treatments (including options of revascularization) should be considered per guideline-directed care </li>- +<li>
- +<strong>CAD-RADS 4A</strong>: consider invasive coronary angiography or functional assessment</li>
- +<li>
- +<strong>CAD-RADS 4B</strong>: invasive coronary angiography is recommended</li>
- +<li>consider symptom-guided anti-ischaemic and preventive pharmacotherapy as well as risk factor modification per guideline-directed care; other treatments (including options of revascularization) should be considered per guideline-directed care </li>
-<li>consider symptom-guided anti-ischaemic and preventive pharmacotherapy as well as risk factors modification per guideline-directed care</li>-<li>other treatments (including options of revascularization) should be considered per guideline-directed care. </li>- +<li>consider invasive coronary angiography and/or viability assessment</li>
- +<li>consider symptom-guided anti-ischaemic and preventive pharmacotherapy as well as risk factors modification per guideline-directed care; other treatments (including options of revascularization) should be considered per guideline-directed care.</li>
-</ul><p><strong>Management of patients presenting with acute chest pain, negative first troponin, negative or non-diagnostic electrocardiogram and low to intermediate risk </strong>(Thrombolysis In Myocardial Infarction (TIMI) risk score <4) (emergency department or hospital setting)<strong>. </strong></p><ul>-<strong>CAD-RADS 0</strong><ul>-<li>no further evaluation of ACS is required</li>-<li>consider other aetiologies</li>-</ul>- +<strong>CAD-RADS N</strong><ul><li>
- +<strong></strong>additional or alternative evaluation may be needed</li></ul>
- +</li>
- +</ul><h5>Acute chest pain, negative first troponin, negative or non-diagnostic electrocardiogram, and low to intermediate risk</h5><ul>
- +<li>
- +<strong>CAD-RADS 0</strong><ul><li>no further evaluation of acute coronary syndrome is required; consider other etiologies</li></ul>
-<li>consider evaluation of non-ACS aetiology, if normal troponin and no ECG changes</li>- +<li>consider evaluation of non-acute coronary syndrome etiology, if normal troponin and no ECG changes</li>
-<li>consider evaluation of non-ACS aetiology, if normal troponin and no ECG changes</li>- +<li>consider evaluation of non-acute coronary syndrome etiology, if normal troponin and no ECG changes</li>
-<li>if clinical suspicion of ACS is high or if high-risk plaque features are noted, consider hospital admission with cardiology consultation</li>- +<li>if clinical suspicion of acute coronary syndrome is high or if high-risk plaque features are noted, consider hospital admission with cardiology consultation</li>
-<li>consider hospital admission with cardiology consultation, functional testing and/or ICA for evaluation and management.</li>-<li>recommendation for anti-ischaemic and preventive management should be considered as well as risk factor modification</li>-<li>other treatments should be considered if presence of haemodynamically-significant lesion.</li>- +<li>consider hospital admission with cardiology consultation, functional testing, and/or invasive coronary angiography for evaluation and management.</li>
- +<li>recommendation for anti-ischemic and preventive management should be considered as well as risk factor modification; other treatments should be considered if presence of hemodynamically significant lesion.</li>
-<li>consider hospital admission with cardiology consultation. Further evaluation with ICA and revascularization as appropriate.</li>- +<li>consider hospital admission with cardiology consultation; further evaluation with invasive coronary angiography and revascularization as appropriate</li>
-<li>consider expedited ICA on a timely basis and revascularization if appropriate if acute occlusion</li>- +<li>consider expedited invasive coronary angiography on a timely basis and revascularization if appropriate if acute occlusion</li>
-<strong>CAD-RADS N</strong><ul><li>additional or alternative evaluation for ACS is needed </li></ul>- +<strong>CAD-RADS N</strong><ul><li>additional or alternative evaluation for acute coronary syndrome is needed </li></ul>
-</ul><p>* ACS - acute coronary syndrome</p><p>If more than one modifier is present, the symbol “/” (slash) should follow each modifier in the following order:</p><ul>-<li>modifier N (non-diagnostic)</li>-<li>modifier S (stent)</li>-<li>modifier G (graft)</li>-<li>modifier V (vulnerability)</li>-</ul><p><strong>For example:</strong></p><ul>- +</ul><h4>Modifiers</h4><p>If more than one modifier is present, the symbol “/” (slash) should follow each modifier in the following order:</p><ul>
- +<li>modifier N: nondiagnostic</li>
- +<li>modifier S: stent</li>
- +<li>modifier G: graft</li>
- +<li>modifier V: vulnerability</li>
- +</ul><p>For example:</p><ul>